NDC 0469-2601

Myrbetriq 25 mg tablet, film coated, extended release

On the label: Astellas Pharma US, Inc..

Japan: 2Ireland: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Astellas Ireland Co., LimitedDublin, IrelandMakes the active ingredient and tests it Problems found, fixed voluntarilyJun 17, 2022 · 4 inspections
Astellas Pharma Inc.Takahagi, JapanMakes the active ingredient and tests it Problems found, fixed voluntarilyJun 6, 2025 · 4 inspections
Sumitomo Chemical Company, LimitedKurashiki, JapanMakes the active ingredient No problems foundNov 2, 2023 · 3 inspections

Product details

Generic drug
Mirabegron: every company that makes it
Form
tablet, film coated, extended release, oral
Strength
25 mg
Approval
NDA NDA202611
On the market since
Jun 28, 2012
Package NDCs
0469-2601-07 0469-2601-30 0469-2601-90
Official label
DailyMed (National Library of Medicine), updated Aug 1, 2024

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?